Survival of hematopoietic and leukemic colony-forming cells in vivo after administration of mitomycin C or porfiromycin.
D000818:Animals; D002455:Cell Division; D002470:Cell Survival / Q000187:drug effects; D002999:Clone Cells; D004305:Dose-Response Relationship, Drug; D005260:Female; D006412:Hematopoietic Stem Cells / Q000187:drug effects*; D007942:Leukemia, Experimental / Q000188:drug therapy*; D008297:Male; D051379:Mice; D008806:Mice, Inbred AKR; D008937:Mitomycins / Q000494:pharmacology* / Q000627:therapeutic use; D011160:Porfiromycin / Q000494:pharmacology* / Q000627:therapeutic use; D051381:Rats; D013997:Time Factors
D008937:Mitomycins; D011160:Porfiromycin